Crispr Therapeutics AG (CRSP) offers a chance to buy into a pipeline of potential therapeutics, that while not yet proven, has shown early success during its clinical trials. While this company does ...
Multiple analysts have issued price targets for $CRSP recently. We have seen 15 analysts offer price targets for $CRSP in the last 6 months, with a median target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback